Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Global Water Resources Declares Monthly Dividend
-
A New Era of Growth and Innovation at JP3E - A Message from the New CEO
-
SAI.TECH Joins World Nuclear Association as New Member and to Participate in World Nuclear Symposium 2024
-
FangDD Reports First Half 2024 Unaudited Financial Results
-
Royal Canadian Legion delegates elect new Executive team and help move agenda forward/ Les délégués de La Légion royale canadienne élisent un nouvel exécutif et contribuent à faire avancer leur
-
Bayport Management Ltd Group Quarterly Report June 2024
-
SAIC Board of Directors Declares Cash Dividend
-
Bayport Management Ltd Audited Abridged December Financial Report December 2023
-
Abridged and Quarterly Group Financial Report March 2024
-
FRO – Q2 2024 Presentation
-
Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
-
Invesco Ltd: Form 8.3 - DS Smith PLC Public dealing disclosure
-
Western Investment Company Revises Previously Announced Transaction
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
-
Alliance Trust PLC - Net Asset Value
-
Total Energy Services Inc. Announces Dividend
-
CHAR Technologies Announces Fiscal 2024 Third Quarter Results
-
Mulvihill Premium Yield Fund Announces Semi-Annual Results
-
Announces Semi-Annual Results
-
Mulvihill Canadian Bank Enhanced Yield ETF Announces Semi-Annual Results
-
S Split Corp. Announces Semi-Annual Results
-
BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced At-The-Market Under Nasdaq Rules
-
Mulvihill U.S. Health Care Enhanced Yield ETF Announces Semi-Annual Results
-
Cellebrite Announces "Redemption Fair Market Value" in Connection with Redemption of All Outstanding Warrants
-
Ventyx Biosciences Announces Departure of Chief Financial Officer
-
Imbria to Present Results from Phase 2 IMPROVE-ISCHEMIA Trial of Ninerafaxstat in Patients with Angina and Chronic Coronary Syndrome at the European Society of Cardiology Congress 2024
-
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
-
Cellebrite Announces "Redemption Fair Market Value" in Connection with Redemption of All Outstanding Warrants
-
HOOKIPA Pharma Announces Board of Directors Changes
-
DIH Appoints Haapsalu Neurological Rehabilitation Center as a DIH Center of Excellence
-
Qomolangma Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Filing of Quarterly Report on Form 10-Q
-
Gentex Announces Third Quarter 2024 Cash Dividend
-
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
-
Disc Medicine to Participate in Upcoming Investor Conferences
-
NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September
-
Jiangsu Glimpses Special Issue: Invitation to Explore the Silk Road Tourism Belt on the East Part of New Eurasian Land Bridge
-
Innofactor Plc: Managers’ Transactions – Martin Söderlind
-
Havila Shipping ASA: Decisions from written resolution in the bond loans Havi04 and Havi07
-
The multifunctional project Akropolis Vingis has been issued a document permitting construction: further stages of the project implementation being planned
-
Opthea Reports Full-Year Financial Results and Business Updates
-
Avicanna Announces Repayment of Debentures
-
Electra to Discuss Partnership Opportunities at Indonesian Critical Minerals Summit
-
LAZCLUZE™ (lazertinib) Now Available from Onco360 for the First-line Treatment, in Combination with Rybrevant®, of Adult Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Have EGFR E
-
Registration of share capital increase in IDEX Biometrics 30 Aug 2024
-
Range Declares Quarterly Dividend
-
Draganfly Confirms Post-Consolidation Trading Date
-
Extraordinary General Meeting - Nykredit Realkredit A/S
-
Form 8.3 - Keywords Studios plc - Octopus Investments
-
Cash Labs Joins Forces with Nick Laws to Launch Catalyst, a Transformative Talent Development Division
